FDA Announces Proposed Collection of Information for Blood and Blood Component Regulations

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to Current Good Manufacturing Practice for Blood and Blood Components and the reduction of transfusion-transmitted infections, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.